Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 317

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 317
---
upAgreement, duly executed by SPAC, Sponsor and the shareholders of SPAC specified therein; and •counterpart signatures to the Assignment, Assumption and Amendment Agreement, duly executed by SPAC. Termination of the Business Combination Agreement The Business Combination Agreement may be terminated and the Transactions abandoned prior to the Merger Effective Time, notwithstanding approval of the Business Combination Agreement by the SPAC Shareholders, as follows: •by mutual written consent of the Company and SPAC; •by written notice from either the Company or SPAC to the other if any Governmental Authority shall have enacted, issued, promulgated, enforced or entered any law (whether temporary, preliminary or permanent) or Governmental Order that has become final and non -appealableand has the effect of making the Closing or Closing illegal or which otherwise prevents or prohibits consummation of the Closing or Closing, other than any such Restraint that is immaterial; •by written notice to SPAC from the Company if the SPAC Shareholders’ Approval shall not have been obtained by reason of the failure to obtain the required vote at the SPAC Shareholders’ Meeting duly convened therefor or at any adjournment thereof; 152 •by written notice to the Company from SPAC if there is any breach of any covenant or agreement on the part of the Company or Merger Sub set forth in the Business Combination Agreement, or if any representation or warranty of the Company, or Merger Sub shall have become untrue or inaccurate as of any subsequent date after the date of the Business Combination Agreement, in any case such that any of the conditions specified in the Business Combination Agreement would not be satisfied at Closing, subject to certain exceptions and cure periods set forth in the Business Combination Agreement; •by written notice from either the Company or SPAC to the other if the Closing has not occurred on or before December9, 2024 (the “Outside Date”); provided, however, that the Business Combination Agreement may not be terminated under this section by or on behalf of any party that either directly or indirectly through its affiliates materially breaches or violates any representation, warranty, covenant, agreement or obligation contained herein and such material breach or violation is the principal cause of the failure to satisfy a condition set forth in the Business Combination Agreement on or prior to December9, 2024 (as the Outside Date has passed, either the Company or OmnigenicsAI may terminate the Business Combination Agreement subject to the foregoing; however, no party to the Business Combination Agreement has elected or expressed an